Welcome to our dedicated page for Iron Horse Acquisit II news (Ticker: IRHO), a resource for investors and traders seeking the latest updates and insights on Iron Horse Acquisit II stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Iron Horse Acquisit II's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Iron Horse Acquisit II's position in the market.
Iron Horse Acquisition II Corp (NASDAQ: IRHO) said that starting February 6, 2026 holders of units from its Dec. 18, 2025 IPO may elect to separately trade ordinary shares and rights on the Nasdaq Global Market.
Each unit contains one ordinary share and one right (each right equals 1/10 of one ordinary share at the time of a business combination). Separated ordinary shares will trade as IRHO, rights as IRHOR, and unseparated units will remain IRHOU. Brokers must contact Continental Stock Transfer & Trust Company to separate units. Cantor Fitzgerald served as sole book-running manager.